MedTrace Logo

Treatment of Osteoarthrosis of the Knee With Platelet Rich Plasma, Comparative Study With Hyaluronic Acid

NCT03477630 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2022-06-16

No results posted yet for this study

Summary

To compare changes in functionality and pain level using questionnaires EVA, Lequesne and WOMAC in patients treated with 4 doses of 8 ml of autologous Platelet Rich Plasma every 15 days applied through intra-articular infiltration and patients treated with an intra-articular infiltration of 1 dose of SYNVISC-ONE ® 6 ml pre-filled syringe, placed according to standard protocol, in patients with OA grade II-IV.

Conditions

Interventions

BIOLOGICAL

Platelet Rich Plasma

intra-articular infiltration of 8 ml of autologous PRP every 15 days.

DRUG

Hyaluronic Acid

intra-articular infiltration of a single dose of HA

Sponsors & Collaborators

  • Karla Andrea Arias Varela

    lead INDIV

Principal Investigators

  • Carlos Palavicini · FIFA MD

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-14
Primary Completion
2020-07-25
Completion
2020-09-16

Countries

  • Costa Rica

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03477630 on ClinicalTrials.gov